Medical Supply Procurement – Dextrose Oral Gel

The contract entails the procurement, packaging, and delivery of Dextrose Oral Gel with National Stock Number 6505014253168 to a U.S. Navy vessel, ensuring full compliance with Defense Logistics Agency and Department of Defense standards. The product is classified under NAICS code 325412, indicating manufacturing in the pharmaceutical and medicine industry, and is being issued as a subcontract under the broader medical supply procurement framework managed by the Defense Logistics Agency. All packaging and handling must meet stringent military specifications to maintain product integrity, sterility, and readiness for emergency medical use aboard naval vessels. Delivery timelines and logistics are tightly coordinated to ensure the supply reaches its designated naval destination without delay, adhering to DoD transport and documentation protocols. Though the specific city or state of performance is not listed, the contract is active under the DLA’s supply chain system, with the official award reference tied to contract number SPE2DX25D9900 and delivery order SPE2DP26F7747. The solicitation was posted on July 18, 2026, and while no set-aside provisions or point of contact details are provided, the procurement is part of the DLA’s ongoing effort to maintain critical medical inventory for deployed U.S. Navy forces.